V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240011536 | 240014229 | 1.63 | null | null | null | 2015-07-09 | Azacitidine | N | N | 240030816 | AZACITIDINE |
| 240011537 | 240014229 | 1.63 | 46.1 | Palliative (P) | 2015-04-24 | 2015-05-07 | Bevacizumab 15mg/kg | Y | N | 240030816 | BEVACIZUMAB |
| 240011538 | 240016101 | 1.63 | 90.7 | Palliative (P) | null | 2014-03-03 | Bevacizumab 15mg/kg | 2 | N | 240030823 | BEVACIZUMAB |
| 240011539 | 240007739 | null | 59.7 | Curative (C) | 2015-03-01 | 2015-03-08 | Methotrexate intrathecal | 2 | N | 240030829 | METHOTREXATE INTRATHECAL |
| 240011540 | 240007740 | null | 90.7 | Curative (C) | 2016-07-13 | 2016-11-05 | BEVACIZUMAB + CARBO + PACLITAXEL | null | N | 240030841 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011541 | 240012159 | null | 13 | Not known (9) | 2013-05-21 | 2013-06-04 | CHOP | N | N | 240030857 | CHOP |
| 240011542 | 240014230 | 1.58 | 70.7 | Adjuvant (A) | 2013-01-13 | 2013-02-28 | INTERLACE TRIAL | N | N | 240030857 | INTERLACE TRIAL |
| 240011543 | 240014230 | 1.67 | 34.7 | Palliative (P) | 2014-04-27 | 2014-04-27 | Azacitidine | N | N | 240030857 | AZACITIDINE |
| 240011544 | 240007741 | 1.75 | null | Palliative (P) | 2017-12-17 | 2018-05-06 | ALCL ALCL 99 Closed AM 1, 2 or 3 | N | N | 240030876 | NOT MATCHED |
| 240011545 | 240007742 | 1.66 | 44 | Curative (C) | null | 2014-01-25 | INTERLACE TRIAL | 1 | null | 240030885 | INTERLACE TRIAL |
| 240011546 | 240007744 | 1.53 | 63 | Unknown (U) | null | 2017-08-16 | Azacitidine | N | N | 240030889 | AZACITIDINE |
| 240011547 | 240007744 | 1.72 | null | Neo-adjuvant (N) | 2015-06-02 | 2015-06-05 | Methotrexate intrathecal | N | N | 240030889 | METHOTREXATE INTRATHECAL |
| 240011548 | 240014231 | 1.81 | null | null | 2014-05-08 | 2014-05-25 | AML Relapsed FLA - Idarubicin | 02 | N | 240030899 | NOT MATCHED |
| 240011549 | 240015287 | 1.88 | 77 | Disease modification (D) | 2015-05-11 | 2015-05-25 | Azacitidine | Y | N | 240030905 | AZACITIDINE |
| 240011550 | 240012162 | 1.61 | null | Neo-adjuvant (N) | 2014-02-16 | 2014-03-03 | ALCL ALCL 99 Closed AM 1, 2 or 3 | 2 | N | 240030910 | NOT MATCHED |
| 240011551 | 240007746 | null | null | Palliative (P) | 2016-10-09 | 2016-10-09 | Paclitaxel 7 day | 1 | N | 240030910 | PACLITAXEL |
| 240011552 | 240007746 | null | 91.8 | Palliative (P) | 2017-10-17 | 2017-10-20 | ALCL ALCL 99 Closed BM 1, 2 or 3 | 02 | N | 240030910 | NOT MATCHED |
| 240011553 | 240007748 | 1.74 | 54.4 | Curative (C) | 2014-03-30 | 2014-04-07 | INTERLACE TRIAL | Y | null | 240030920 | INTERLACE TRIAL |
| 240011554 | 240012164 | 0 | 59.2 | Curative (C) | 2013-04-01 | 2013-09-18 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 240030925 | PACLITAXEL |
| 240011557 | 240012167 | 1.67 | 96 | Palliative (P) | 2014-01-06 | 2014-01-10 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240030942 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011558 | 240014236 | 1.9 | 103 | Palliative (P) | 2018-02-19 | 2018-02-27 | Bevacizumab 15mg/kg | N | N | 240030946 | BEVACIZUMAB |
| 240011559 | 240014237 | 1.54 | 71 | Disease modification (D) | null | 2017-11-16 | ALCL ALCL 99 Closed BM 1, 2 or 3 | Y | N | 240030946 | NOT MATCHED |
| 240011560 | 240015823 | null | 63.6 | Curative (C) | 2013-04-30 | 2013-05-20 | Azacitidine | Y | null | 240030954 | AZACITIDINE |
| 240011561 | 240015823 | 1.88 | 58 | Palliative (P) | 2014-09-21 | 2014-09-21 | Bevacizumab+Carbo+Pacliaxel | 99 | null | 240030954 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011562 | 240016321 | null | 70.55 | Curative (C) | 2017-04-11 | 2017-08-11 | Azacitidine | null | null | 240030978 | AZACITIDINE |
| 240011563 | 240012169 | 1.65 | 62.6 | Curative (C) | 2016-04-25 | 2016-05-13 | Trial Unspecified | N | N | 240030978 | TRIAL |
| 240011564 | 240007756 | null | 65.9 | Curative (C) | 2013-09-09 | 2014-03-17 | Trial Unspecified | 2 | N | 240030987 | TRIAL |
| 240011565 | 240012170 | null | 70.4 | Neo-adjuvant (N) | 2014-11-29 | 2014-12-02 | Bevacizumab | N | N | 240030989 | BEVACIZUMAB |
| 240011566 | 240007758 | 1.53 | 80 | Curative (C) | 2018-07-15 | 2018-07-15 | ALCL ALCL 99 Closed AM 1, 2 or 3 | N | N | 240030991 | NOT MATCHED |
| 240011567 | 240007759 | 1.66 | 78.5 | null | 2017-02-09 | 2017-03-29 | Methotrexate intrathecal | N | N | 240030993 | METHOTREXATE INTRATHECAL |
| 240011568 | 240014240 | 1.68 | null | null | 2018-03-18 | 2018-03-28 | Bevacizumab | Y | N | 240030997 | BEVACIZUMAB |
| 240011569 | 240007761 | 1.62 | null | Disease modification (D) | null | 2017-12-14 | Azacitidine | 02 | N | 240031000 | AZACITIDINE |
| 240011570 | 240014242 | null | 53.5 | null | 2014-04-16 | 2014-04-17 | Trial Unspecified | 2 | N | 240031013 | TRIAL |
| 240011571 | 240007763 | 1.81 | 67.9 | Curative (C) | 2017-08-09 | 2017-08-09 | ALCL ALCL 99 Closed AM 1, 2 or 3 | 02 | N | 240031031 | NOT MATCHED |
| 240011572 | 240007763 | 1.62 | null | Palliative (P) | null | 2015-04-06 | Bevacizumab 15mg/kg | 02 | N | 240031031 | BEVACIZUMAB |
| 240011573 | 240007764 | 1.66 | 59 | Palliative (P) | null | 2016-05-28 | Trial Unspecified | null | null | 240031041 | TRIAL |
| 240011574 | 240007765 | 1.78 | 65.5 | null | 2014-09-21 | 2014-09-23 | CHOP | 02 | N | 240031048 | CHOP |
| 240011575 | 240007766 | 1.68 | 30.2 | Palliative (P) | 2015-06-24 | 2015-07-02 | Trial Unspecified | Y | null | 240031054 | TRIAL |
| 240011576 | 240007767 | null | 110 | Curative (C) | 2015-01-21 | 2015-01-21 | Trial Unspecified | N | N | 240031063 | TRIAL |
| 240011577 | 240012176 | 1.64 | null | Palliative (P) | 2015-01-01 | 2015-01-04 | PACLITAXEL | 2 | N | 240031064 | PACLITAXEL |
| 240011578 | 240012176 | null | 92 | Curative (C) | 2014-11-16 | 2015-01-15 | Azacitidine | N | N | 240031064 | AZACITIDINE |
| 240011579 | 240014245 | 1.89 | 32.2 | Palliative (P) | 2013-01-13 | 2013-08-03 | Methotrexate intrathecal | 2 | N | 240031076 | METHOTREXATE INTRATHECAL |
| 240011580 | 240007770 | 1.7 | 102.1 | Palliative (P) | 2013-09-23 | 2013-09-29 | Trial Unspecified | 2 | N | 240031088 | TRIAL |
| 240011581 | 240007772 | 1.56 | 89.6 | Disease modification (D) | 2016-06-07 | 2016-06-14 | SMILE | N | N | 240031088 | TRIAL |
| 240011582 | 240007773 | 1.69 | 35 | Neo-adjuvant (N) | 2015-03-19 | 2015-06-13 | Carboplatin AUC 2 - 5 | N | N | 240031095 | CARBOPLATIN |
| 240011583 | 240007774 | null | 58 | Adjuvant (A) | 2015-04-22 | 2015-04-22 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 240031098 | PACLITAXEL |
| 240011584 | 240012179 | 1.62 | 62.3 | null | 2013-10-31 | 2013-11-29 | MaxiCHOP (>Cycle 2) | N | N | 240031099 | CHOP |
| 240011585 | 240007775 | 1.75 | 47.6 | null | 2018-12-06 | 2018-12-06 | Bevacizumab | 02 | N | 240031101 | BEVACIZUMAB |
| 240011586 | 240012181 | 1.56 | 79.7 | null | 2018-05-12 | 2018-05-19 | Trial Unspecified | N | N | 240031101 | TRIAL |
| 240011587 | 240007779 | null | 60.8 | Palliative (P) | 2015-11-03 | 2017-05-02 | BEVACIZUMAB + CARBO + PACLITAXEL | 2 | null | 240031114 | BEVACIZUMAB + CARBO + PACLITAXEL |